Robert Franz Helicobacter pylori (lactobacillus reuteri) Capsules 60 pcs
Please note: The manufacturer Robert Franz has changed the name of its products. Accordingly, they are now labeled as suitable for animals. Further information can be found on the manufacturer's website.
Robert Franz Helicobacter pylori (lactobacillus reuteri) Capsules
For the dietary management of Helicobacter pylori. Not suitable for use as the sole source of nutrition. Use under medical supervision. Store at room temperature. Keep out of reach of children.
Ingredients:
Lactobacillus reuteri DSM17648 (inactivated), bulking agent: rice flour, capsule shell: HPMC
| Per 100 g | 2 capsules | |
| Lactobacillus reuteri DSM17648 (inactivated) | 61.3 g | 2 x 10 10 = 20,000,000,000 = 20 billion (400 mg) |
| Calorific value kJ/kcal | 1174/280 | |
| Fat | 0.16 g | |
| of which saturated fatty acids | 0 g | |
| Carbohydrates | 50.3 g | |
| of which sugar | 2.2 g | |
| protein | 5.3 g | |
| Salt 1 | 0.35 g |
Recommended intake:
Take 2 capsules daily with liquid immediately before or during solid meals. Helicopter capsules contain an inactivated Lactobacillus reuteri strain for the dietary management of gastric mucosal inflammation caused by Helicobacter pylori infection. It can specifically bind Helicobacter pylori in the stomach and cause it to be excreted.
Note:
Do not exceed the recommended daily intake. Food supplements should not be used as a substitute for a balanced and varied diet. Keep out of reach of children.
Helicobacter pylori benefits:
Helicobacter pylori (H. pylori) infection has potential benefits, including reducing risks for obesity, asthma, inflammatory bowel disease (IBD), and Barrett's esophagus. It may also help regulate hunger hormones like ghrelin and modulate immune responses to vaccines. However, these benefits must be weighed against the well-known risks, such as peptic ulcers and gastric cancer.
Potential Benefits
Reduced risk of certain diseases: Studies suggest that H. pylori infection is associated with a lower risk of developing some diseases, including obesity, childhood asthma, and inflammatory bowel disease.
Protection against reflux-related esophageal conditions: Infection may reduce the risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Modulation of hormones: The bacteria may influence satiety hormones like ghrelin and leptin, potentially affecting weight regulation.
Immune system regulation: Some evidence suggests that H. pylori infection can strengthen the immune response to oral vaccines.